Follow-up and outcome of patients with primary BH4 deficiencies - Takeaways - MDSpire

Follow-up and outcome of patients with primary BH4 deficiencies

  • By

  • Francesca Nardecchia

  • Filippo Manti

  • Agnese De Giorgi

  • Serena Galosi

  • Jennifer Friedman

  • Vincenzo Leuzzi

  • July 16, 2026

Share

  • 1

    BH4 deficiencies can occur with or without hyperphenylalaninemia, affecting clinical follow-up and treatment goals.

  • 2

    Neurodevelopmental impairment and movement disorders are common symptoms across most BH4 deficiency conditions.

  • 3

    Monitoring blood Phe levels and conducting brain MRI are essential for managing patients with BH4 deficiencies.

  • 4

    Clinical outcomes vary significantly based on the timing of treatment and the severity of metabolic derangement.

  • 5

    Standardized assessment tools are necessary for future studies to evaluate neurological and behavioral impairments.

Original Source(s)

Follow-up and outcome of patients with primary BH4 deficiencies

  • by Francesca Nardecchia, Filippo Manti, Agnese De Giorgi, Serena Galosi, Jennifer Friedman, Vincenzo Leuzzi

  • July 16, 2026

Related Content

Global research trends and hotspots of short-chain fatty acids in cognitive impairment: a bibliometric analysis based on two databases

Transcutaneous vagus nerve stimulation in sleep disorders: current evidence and future directions

Salivary Cortisol and Cognitive Decline and Alzheimer Disease in Older Adults